Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma - Wikidata - awgldk - TriplyDB

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

http://www.wikidata.org/entity/Q36421817

about

Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.Relationship of hypoxia-inducible factor 1alpha and p21WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer.Prognostic significance of p21 and p53 expression in gastric cancer.Expression of p21(WAF1) and p53 and polymorphism of p21(WAF1) gene in gastric carcinoma.p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.Loss of BCL2L10 protein expression as prognostic predictor for poor clinical outcome in gastric carcinoma.Effects of interferon alpha on the expression of p21cip1/waf1 and cell cycle distribution in carcinoid tumors.Interplay between p53 and VEGF: how to prevent the guardian from becoming a villain.Comparative study of non-functional islet cell tumors and pancreatic solid and papillary neoplasms: biological behavior and immunohistochemistry.p16Ink4a is overexpressed in H. pylori-associated gastritis and is correlated with increased epithelial apoptosis.Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma.The prognostic significance of p21 and Her-2 gene expression and mutation/polymorphism in patients with gastric adenocarcinoma.Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach.p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.Decreased p21 expression in HPV-18 positive cervical carcinomas.

P2860

Q35200395-8537D911-AD02-4B56-8ECE-561AF5E30DC5 Q35250784-23DAAED1-19B5-49BF-8001-5FECF66C2FA2 Q35937130-3A57551B-51F2-429F-9051-80E45F714D12 Q36308280-40CA992C-0FDD-4E20-827E-02936B741342 Q36619342-23BE9934-5540-4D04-BFAA-77ABD93E417F Q36641213-D212156C-910E-4EF9-B359-3C4CCB2A88BD Q36641858-D59105B4-3D64-4FFB-A6F8-7753A1DD4479 Q37159866-7DCA993F-066A-48A6-BE5F-6C465BB916F1 Q39458618-01C10170-A901-4395-83D2-02074AFE122F Q39618916-8BEF33B7-D473-42B6-ACDE-ED17D86DDC99 Q40730294-5C0C7538-F2A6-45C2-93B8-15BE11EEC451 Q43130505-382A8386-1836-4CE9-85B6-C5BA3A6D705A Q44052073-925D4C87-CF6E-4DF5-8F11-3AC812215EB7 Q44326414-DD45B465-8A35-43E1-BBF2-C208D910787C Q46213204-CC31F1CF-A096-4925-A9E9-E32B310480DA Q47705274-C91779A8-CAF7-4520-92DE-7C4074CDC0B9 Q50305520-CBE0EFA8-B6AC-45ED-9349-CACBAA71F586 Q53127108-026EA69C-8BAA-4036-A1F2-E2A0A9934D63 Q53358768-03958084-22D9-4FD9-9CFC-582A11407834 Q53414775-56E937C1-3121-4F0D-B0CF-169DA1FAC23B Q54470540-3A8CC6D2-BD7D-4100-BDE4-8854410A18D9

P2860

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

http://www.wikidata.org/entity/Q36421817

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

@ast

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

@en

type

label

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

@ast

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

@en

prefLabel

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

@ast

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

@en

P1433

Q36421817-D40E5B27-D5FC-49A5-A309-40C4C1C7D4F0

P1476

Q36421817-1FD66D0C-D27B-4DCA-AA87-0A9D57AAA035

P2093

Q36421817-1335A7C3-9F08-4360-BEDD-104F5DF0000D

Q36421817-25669A25-0063-42B3-94A5-21E6438092A6

Q36421817-2A161BD2-8A4B-486B-A7B5-BFF7B30060CD

Q36421817-729A755C-8940-45B6-8510-CDDE7C0BDC6C

Q36421817-C0627D14-4CA8-4832-9F52-06ABAF01A1A4

P2860

Q36421817-03FC048C-DC85-4DF3-80AF-EED25488ECE4

Q36421817-09DBE830-D1CF-452D-AB7B-B575EEECA6A6

Q36421817-1582AEB8-5EF7-4636-ACD6-20E9610BE7B5

Q36421817-226C9357-922A-4DFA-AB32-2D4342DBA03B

Q36421817-2C601F6F-47D4-4A92-AEF3-A29CFC12D081

Q36421817-3EC1F5BB-53BD-44C1-8FC6-40A8A25F1479

Q36421817-4E7AA9C2-CDD6-49AD-A21B-E65B9AE8F3E5

Q36421817-5A4C4B0A-9F3A-4C9F-9DAC-EC4FFC7FF6C9

Q36421817-6FE56919-2EFC-45F6-9D04-013A60CF3558

Q36421817-78821F76-33D7-4573-ABFF-518D1A3A937C

P2888

Q36421817-59BBBD5E-D1CC-45AB-BCB0-FC740B591E23

P304

Q36421817-ED79AFEE-97D1-4F18-B24F-A7221475E32A

P31

Q36421817-72668F5F-2D29-4639-A4E0-6473022A1460

P356

Q36421817-2A05C599-569A-49F5-9AE9-19522B959272

P407

Q36421817-92442D09-1CFF-43E1-92FF-7EC964F2E345

P433

Q36421817-88924AE9-E795-460E-830E-72989F9E5599

P478

Q36421817-8FFA87D7-A234-45B5-8C15-083202B76B51

P577

Q36421817-50DA3365-5515-4712-810C-82A0C9A87F40

P5875

Q36421817-7B0F65F3-8E5A-446D-A4B9-54E573B9377F

P6179

Q36421817-D1667E9B-1BBC-43B3-9DBC-867BE39FD709

P698

Q36421817-2A1D9B65-6BD9-4683-80B7-9EB94A63A0B9

P932

Q36421817-A44C0019-982C-488C-B890-69F1A5F38298

P356

P1433

British Journal of Cancer

P1476

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

@en

P2093

Chung YS

http://www.w3.org/2001/XMLSchema#string

Maeda K

http://www.w3.org/2001/XMLSchema#string

Ogawa M

http://www.w3.org/2001/XMLSchema#string

Onoda N

http://www.w3.org/2001/XMLSchema#string

Sowa M

http://www.w3.org/2001/XMLSchema#string

P2860

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

WAF1, a potential mediator of p53 tumor suppression

p21 is a universal inhibitor of cyclin kinases

Retinoblastoma gene structure and product expression in human gastric carcinomas.

Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.

The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.

Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis.

Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.

Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.

P2888

P304

1617-1620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1997.276

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14035049

http://www.w3.org/2001/XMLSchema#string

P6179

1027549841

http://www.w3.org/2001/XMLSchema#string

P698

9184177

http://www.w3.org/2001/XMLSchema#string

P932

2223544

http://www.w3.org/2001/XMLSchema#string